The Role of Toll-Like Receptors in Hematopoietic Malignancies
Open Access
- 28 September 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 7, 390
Abstract
Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs) that shape the innate immune system by identifying pathogen-associated molecular patterns (PAMPS) and host-derived damage associated molecular patterns (DAMPS). TLRs are widely expressed on both immune cells and non-immune cells, including hematopoietic stem and progenitor cells, effector immune cell populations, and endothelial cells. In addition to their well-known role in the innate immune response to acute infection or injury, accumulating evidence supports a role for TLRs in the development of hematopoietic and other malignancies. Several hematopoietic disorders, including lymphoproliferative disorders and myelodysplastic syndromes, which possess a high risk of transformation to leukemia, have been linked to aberrant TLR signaling. Furthermore, activation of TLRs leads to the induction of a number of pro-inflammatory cytokines and chemokines, which can promote tumorigenesis by driving cell proliferation and migration and providing a favorable microenvironment for tumor cells. Beyond hematopoietic malignancies, the upregulation of a number of TLRs has been linked to promoting tumor cell survival, proliferation, and metastasis in a variety of cancers, including those of the colon, breast, and lung. This review focuses on the contribution of TLRs to hematopoietic malignancies, highlighting the known direct and indirect effects of TLR signaling on tumor cells and their microenvironment. In addition, the utility of TLR agonists and antagonists as potential therapeutics in the treatment of hematopoietic malignancies is discussed.Keywords
This publication has 109 references indexed in Scilit:
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammationJournal of Experimental Medicine, 2011
- Inflammatory signals regulate hematopoietic stem cellsTrends in Immunology, 2011
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cellsLeukemia, 2010
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotypeNature Medicine, 2009
- Cancer Cells Expressing Toll-like Receptors and the Tumor MicroenvironmentCancer Microenvironment, 2009
- UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomesNature, 2008
- Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System ReplenishmentImmunity, 2006
- The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9Nature Immunology, 2006